There are novel agents and new forms of chemotherapy in development for patients with inoperable, stage IV pancreatic cancer, says Choti. The strategy for these patients are to find effective therapies for which chemotherapy is applied in neoadjuvant or potentially curative situations. Watch here . . .
Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the future of treatment for patients with stage IV pancreatic cancer.